Myeloid TAKI [corrected] acts as a negative regulator of the LPS response and mediates resistance to endotoxemia
about
TNF and MAP kinase signalling pathways.Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in miceIntravenous delivery of HIV-based lentiviral vectors preferentially transduces F4/80+ and Ly-6C+ cells in spleen, important target cells in autoimmune arthritis.Activated macrophage survival is coordinated by TAK1 binding proteinsTumor necrosis factor receptor-associated factor 6 (TRAF6) and TGFβ-activated kinase 1 (TAK1) play essential roles in the C-type lectin receptor signaling in response to Candida albicans infection.TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.TAK1 regulates hepatic cell survival and carcinogenesis.Protein kinase networks that limit TLR signalling.Inhibitory Fcγ receptor is required for the maintenance of tolerance through distinct mechanisms.Adenovirus-Mediated Small Interfering RNA Targeting TAK1 Ameliorates Joint Inflammation with Collagen-Induced Arthritis in Mice.Negative role of TAK1 in marginal zone B-cell development incidental to NF-κB noncanonical pathway activation.Myeloid-specific TAK1 deletion results in reduced brain monocyte infiltration and improved outcomes after stroke.
P2860
Q33905516-C430F0C7-62D2-45C6-8720-CAFE67100641Q34516262-1CEE5BAC-1670-48C6-8439-1C5AB35F45B2Q34580053-E8D9B5A2-BDDD-439A-84F6-6EFD7FF76D10Q35149590-0578A40D-AD0F-4DFA-B1DF-99A59AF26EECQ36492765-840031FD-3502-42BA-BD9F-9EC24B54B046Q36560045-C5FEAB43-970E-4029-92A5-FD844C6CBC4FQ38180064-3B1EA81E-50F8-4B53-B767-3B8D32EFF1BEQ38180755-119EC5CB-081D-4CD4-9880-E0ED2C97D33BQ38538598-D4CDA630-71EC-4856-B0C7-221D696F4AB1Q40324590-AF12D52C-733F-4A3C-AEE1-CCD8FAAFAA83Q41522612-C53929D6-46F7-401B-B163-BEB2E2229950Q54978778-62D13BBB-B8A5-46A6-A0AC-8845725EB883
P2860
Myeloid TAKI [corrected] acts as a negative regulator of the LPS response and mediates resistance to endotoxemia
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Myeloid TAKI [corrected] acts ...... ates resistance to endotoxemia
@ast
Myeloid TAKI [corrected] acts ...... ates resistance to endotoxemia
@en
Myeloid TAKI [corrected] acts ...... ates resistance to endotoxemia
@nl
type
label
Myeloid TAKI [corrected] acts ...... ates resistance to endotoxemia
@ast
Myeloid TAKI [corrected] acts ...... ates resistance to endotoxemia
@en
Myeloid TAKI [corrected] acts ...... ates resistance to endotoxemia
@nl
prefLabel
Myeloid TAKI [corrected] acts ...... ates resistance to endotoxemia
@ast
Myeloid TAKI [corrected] acts ...... ates resistance to endotoxemia
@en
Myeloid TAKI [corrected] acts ...... ates resistance to endotoxemia
@nl
P2093
P2860
P1433
P1476
Myeloid TAKI [corrected] acts ...... ates resistance to endotoxemia
@en
P2093
Christina Eftychi
Maria Alexiou
Maria Apostolaki
Niki Karagianni
P2860
P304
P356
10.1371/JOURNAL.PONE.0031550
P407
P577
2012-02-14T00:00:00Z